Find a Doctor

Jinwei Cheng

MD

———— Personal Information ————

Dr. Cheng conducts basic and clinical research in the areas of thyroid eye disease, orbital and lacrimal tumors, and specially focuses on evidence-based ophthalmology. He is the principle investigator of several nationally and federally funded research projects, and have published more than 90 papers.

Publications

1.Wu J, Zhou H, Wei R, Cheng J. Bilateral cellulitis caused by invasive aspergillosis associated with bilateral intraorbital abscesses: a case report. BMC Ophthalmol. 2020;20(1):330.

2.Wang W, Cheng J. Solitary fibrofolliculoma of the upper eyelid in a 68-year old female: a case report. BMC Ophthalmol. 2020;20(1):97.

3.Zhao LQ, Yu DY, Cheng JW. Intravenous glucocorticoids therapy in the treatment of Graves' ophthalmopathy: a systematic review and Meta-analysis. Int J Ophthalmol. 2019;12(7):1177-1186.

4.Mou P, Chen Z, Jiang L, Cheng J, Wei R. PTX3: A Potential Biomarker in Thyroid Associated Ophthalmopathy. Biomed Res Int. 2018;2018:5961974.

5.Cheng JW, Cheng SW, Wei RL, Lu GC. Anti-vascular endothelial growth factor for control of wound healing in glaucoma surgery. Cochrane Database Syst Rev. 2016;1:CD009782.

PROJECTS

1.      National Natural Science Foundation of China (81170874): The effect of osteopontin on the fibrosis of extraocular muscle in thyroid-associated ophthalmopathy.

2.      National Natural Science Foundation of China (81000374): The effect and mechanism of osteopontin and monoclonal antibody on scar formation after glaucoma filtering surgery.

3.      Shanghai Rising-Star Program, China (12QA1404600): The effect and mechanism of osteopontin on corneal neovascularization.


———— Specialty ————

Dr. Cheng conducts basic and clinical research in the areas of thyroid eye disease, orbital and lacrimal tumors, and specially focuses on evidence-based ophthalmology.